A recent review pinpointed several candidate biomarkers that can be used in the TBE diagnostic, prognostic, and monitoring stages; these include chemokines such as CCL2, CCL7, CXCL1, CXCL2, CXCL9, and CXCL12 [196]. Here, CXCL12 is linked to tick-borne encephalitis.